ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Genetics, Metabolism and Weight Loss in Older, Obese Veterans

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018330
  Purpose

This study is designed to determine whether sequence variation in the lipoprotein lipase (LPQ) gene affects the amount of weight loss and metabolic responses during a hypocaloric diet treatment for overweight and obese (BMI=25-35 kg/m2), older (50-65 yrs), sedentary veterans.


Condition Intervention
Obesity
Behavioral: Weight Loss

MedlinePlus related topics:   Obesity    Weight Control   

ChemIDplus related topics:   Lipase   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Non-Randomized, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:   Genetics, Metabolism and Weight Loss in Older, Obese Veterans

Further study details as provided by Department of Veterans Affairs:

Study Start Date:   April 1999
Estimated Study Completion Date:   March 2004

Detailed Description:

Veterans who are 50-65 yrs, non-smoking, sedentary and weight stable with a BMI between 25-35 kg/m2 (120-150% desirable body weight) are recruited and screened via telephone, medical history, and physical exam. Exclusion criteria are: diabetes, hypertriglyceridemia (>400 mg/dl), history of cancer or myocardial infarction, clinical depression, renal, liver or hematologic disease, and medications that affect glucose or lipid metabolism (thiazides, estrogen replacement, beta-blockers). Changes in total and visceral body fat are measured by dual x-ray absorptiometry and computerized tomography, resting energy expenditure and fat oxidation rate by indirect calorimetry, and lipoprotein lipids by enzymatic assay. Glucose tolerance is assessed during a three-hour oral glucose tolerance test with measurement of glucose- and insulin levels every 30 minutes. LPL activity is measured in 3050mg pieces of subcutaneous abdominal and gluteal adipose tissue.

  Eligibility
Ages Eligible for Study:   50 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria
  • 50-65 yrs, non-smoking, sedentary and weight stable with a BMI between 25-35 kg/m2 (120-150% desirable body weight) are recruited and screened via telephone, medical history, and physical exam.

Exclusion criteria:

  • Diabetes,
  • Hypertriglyceridemia (>400 mg/dl),
  • History of cancer or myocardial infarction,
  • Clinical depression,
  • Renal, liver or hematologic disease, and
  • Medications that affect glucose or lipid metabolism (thiazides, estrogen replacement, beta-blockers).
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018330

Locations
United States, Maryland
VA Maryland Health Care System    
      Baltimore, Maryland, United States, 21201

Sponsors and Collaborators
  More Information

Study ID Numbers:   AGCG-006-98F
First Received:   July 3, 2001
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00018330
Health Authority:   United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Behavioral  
Weight Loss  
Genetics  
Lipoprotein lipase
Visceral fat
Lipoprotein

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overweight
Overnutrition

ClinicalTrials.gov processed this record on August 21, 2008




Links to all studies - primarily for crawlers